The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays.
 
Ryma Benayed
No Relationships to Disclose
 
Michael David Offin
No Relationships to Disclose
 
Kerry A. Mullaney
No Relationships to Disclose
 
Purvil Sukhadia
No Relationships to Disclose
 
Kelly M. Rios
No Relationships to Disclose
 
Patrice Desmeules
No Relationships to Disclose
 
Jason C. Chang
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - ArQule; AstraZeneca; Atara Biotherapeutics; Bayer; Boehringer Ingelheim; Chugai Pharma; CytomX Therapeutics; Debiopharm Group; Genentech; Pfizer
Research Funding - AstraZeneca; Loxo; Puma Biotechnology
 
Michael F. Berger
Research Funding - Illumina
 
Ahmet Zehir
No Relationships to Disclose
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca
 
Alexander E. Drilon
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Genentech/Roche; Ignyta; Loxo; Pfizer; Takeda; TP Therapeutics
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - NCCN/AstraZeneca; NCCN/Boehringer Ingelheim
Research Funding - Loxo (Inst)